Cannabis Patient Care

Shaping the Cannabis Industry with Corporate Social Responsibility: A GMP Collective Webinar In the eighteenth installment of the GMP Collective's webinar series, a panel of industry specialists offered their insights and tips in “From Risk to Reward: The Bottom Line Benefits of DEI and ESG Implementation.” They explained how the values of Diversity, Equity, and Inclusion (DEI) and Environmental, Social, and Governance (ESG) play an important role in the future of the cannabis industry. ➡️ Read highlights, takeaways, and more here: https://ow.ly/Ku8450QNIur

Growing Opportunities: A Look Inside Saint Louis University's Cannabis Science and Operations Program Ever wondered what cannabis educational courses are like? In this interview, Stacy Godlewski, director of Saint Louis University’s Cannabis Science and Operations program, shares insights into how the program prepares its students for successful careers in various areas of cannabis business. Saint Louis University (SLU) in Missouri offers a Certificate in Cannabis Science and Operations, earned through online courses on various topics in the cannabis industry, from cultivation and manufacturing to dispensary ownership and pharmacological properties. ➡️ Read about the courses, instructors, innovation, and more: https://ow.ly/wwYJ50QLUBc

Check Out What's New in the January/February 2024 Issue of Cannabis Science and Technology! In our first issue of the year, we tackle calibration science, hemp responses to light treatments, automation in cannabis extraction, and much more! ➡️ View our interactive issue here: https://ow.ly/qmVP50QJFyJ

Empowerment through Education, Part VII: Rescheduling, Banking, and Beyond Here, Jeremy Robbins and David Benedicktus, co-founders of Cannabis Patients Pacific Northwest (CPPNW), share which challenges cannabis patients and consumers face that they hope to see change in the next five years and why being in a cannabis business is a labor of love. ➡️ Join us for the final installment of this multipart interview series: https://ow.ly/2m3950QIlWo

On This Testing Thursday: Safeguarding Consumers in the Era of Intoxicating Hemp and Synthetic Cannabinoids David Vaillencourt, CEO of the GMP Collective, hosted a recent webinar, “Intoxicating Hemp and Synthetic Cannabinoids: Insights into Lab Testing,” which provided an in-depth discussion on the latest information and complications arising from synthetic cannabinoids available to consumers. ➡️ Read highlights and more: https://ow.ly/6MH850QGNn4

Cannabis for Neurodegenerative Disorders Here, we take a deep dive into research on how cannabis affects neurodegenerative disorders such as Alzheimer’s disease, multiple sclerosis, and Parkinson’s disease. ➡️ Read the full blog installment: https://ow.ly/4q8i50QFKZV

In Case You Missed It: Studies on Cannabis for Anxiety and PTSD: A New Webinar from Healer The latest Healer webinar, led by Dr. Dustin Sulak, provided a research update and analysis on recent studies that treated anxiety and PTSD symptoms with cannabis. ➡️ Read highlights and insights here: https://ow.ly/rW5N50QC47c

Empowerment through Education, Part VI: Cannabis Courses and Outreach In Part VI, co-founders of Cannabis Patients Pacific Northwest (CPPNW) Jeremy Robbins and David Benedicktus, share details about their college cannabis courses, the outreach groups they support with their education, and a few stories of how patients over the years have benefitted from their knowledge. ➡️ Catch up on the latest installment of this interview series: https://ow.ly/sTo950QAKps

On This Week's Testing Thursday: Embracing the Future: The Impact of Cannabis as a Schedule III Substance and the Crucial Role of cGMP 211 Certification In this blog, we explore the potential implications of cannabis becoming a Schedule III substance and why obtaining current Good Manufacturing Practices (cGMP) 211 Certification from an accredited certifying body is crucial for ensuring the longevity and success of cannabis businesses. ➡️ Learn more about the knowns and unknowns: https://ow.ly/uua750Qzjpt

Empowerment through Education, Part V: Navigating Medical Cannabis Regulations In Part V of this interview series, Jeremy Robbins and David Benedicktus, co-founders of Cannabis Patients Pacific Northwest (CPPNW), explain how physician perspective, the current scheduling of cannabis, and the differing state laws surrounding medical cannabis create challenges for accessing cannabis education and medicine. ➡️ Catch up on the latest installment: https://ow.ly/FSRk50Qypci